PhD student
Utrecht University, Netherlands
Christine van Hattem is a PhD student at the Utrecht Institute for Pharmaceutical Sciences (Utrecht University) in the Netherlands. Christine obtained a BSc in Biomedical Sciences and a MSc in Drug Innovation at Utrecht University. During her studies she developed a special interest in the (pre-)clinical and regulatory aspects of developing novel medicinal products. As such, her PhD project focuses on the regulation of and ultimately improving patient access to Advanced Therapy Medicinal Products (ATMPs), as part of DARE-NL, a national platform for gene- and cell therapies. Her presentation at ISPEMY2023 results from a collaborative effort with the Dutch Medicines Evaluation Board.
Disclosure information not submitted.
Tuesday, April 25, 2023
4:00 PM – 5:30 PM GMT